Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis

Clinical trial NCT00033891 · COMPLETED

Trial details

NCT number: NCT00033891
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatomyositis Polymyositis

Start date: 2002-04-10
Primary completion: 2007-07-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.